
Guardant Health GH
$ 94.92
-3.79%
Quarterly report 2026-Q1
added 05-07-2026
Guardant Health Cash Conversion Cycle 2011-2026 | GH
Annual Cash Conversion Cycle Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 79.6 | 76.1 | 54.5 | 79.1 | 73.7 | 64.5 | 76.5 | 131 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 131 | 54.5 | 79.4 |
Quarterly Cash Conversion Cycle Guardant Health
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 85.8 | 87.2 | - | 45 | 79.1 | 71.8 | - | 55.9 | 57.8 | 65.4 | - | 33.5 | 35.2 | 86.4 | - | 55.1 | 50.4 | 58.8 | - | 65.2 | 73.3 | 68.5 | - | 72 | 81.1 | 104 | - | 150 | 168 | 132 | - | 52.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 168 | 33.5 | 76.4 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Co-Diagnostics
CODX
|
-2.46 K | $ 1.29 | -21.17 % | $ 1.72 M | ||
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 15.7 | -3.03 % | $ 475 M | ||
|
Agilent Technologies
A
|
111 | $ 111.7 | -1.38 % | $ 34 B | ||
|
Castle Biosciences
CSTL
|
31.6 | $ 19.13 | 1.32 % | $ 555 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Illumina
ILMN
|
142 | $ 142.54 | -0.49 % | $ 22.7 B | ||
|
Interpace Biosciences
IDXG
|
62.9 | $ 1.76 | -2.22 % | $ 7.79 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 19.97 | -2.54 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
97.3 | $ 93.91 | -2.86 % | $ 6.34 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
66.4 | $ 1 031.64 | -0.99 % | $ 21.3 B | ||
|
Myriad Genetics
MYGN
|
49.3 | $ 3.58 | -1.1 % | $ 332 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 415.27 | -0.93 % | $ 12 B | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
82.4 | $ 8.24 | -1.44 % | $ 1.06 B | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
29.4 | $ 18.62 | -1.64 % | $ 417 M | ||
|
Charles River Laboratories International
CRL
|
65 | $ 150.85 | -5.2 % | $ 7.48 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
81.5 | $ 186.36 | -5.36 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 25.23 | -1.06 % | $ 23.9 B | ||
|
Senseonics Holdings
SENS
|
36.1 | $ 5.77 | -0.86 % | $ 241 M | ||
|
Personalis
PSNL
|
-1.89 | $ 6.36 | -5.22 % | $ 568 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 116.38 | -0.61 % | $ 9.6 B | ||
|
Soleno Therapeutics
SLNO
|
-398 | $ 53.01 | 0.04 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
172 | $ 2.34 | -2.9 % | $ 5.38 M | ||
|
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 250.4 | -1.43 % | $ 20.8 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 438.34 | -2.2 % | $ 165 B | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.57 | -1.59 % | $ 205 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
83.6 | $ 49.17 | -7.14 % | $ 2.94 B | ||
|
Waters Corporation
WAT
|
731 | $ 329.22 | -1.2 % | $ 19.6 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 8.19 | -2.85 % | $ 1.78 B | ||
|
Quest Diagnostics Incorporated
DGX
|
39.5 | $ 186.61 | -0.71 % | $ 20.7 B |